Back to Trials
NCT07145411Recruiting

HPC Offered for PRESERVE Expansion

Ossium Health, Inc.

Start Date

6/27/2024

Completion Date

8/1/2029

Summary

Ossium recognizes that not all patients who could benefit from Ossium's HPC, Marrow can access the PRESERVE trial for logistical or eligibility reasons. The HOPE program is expanded access program to serve these patients by providing our bone marrow product

Eligibility Criteria

Age Range: 12 years to 80 years

Inclusion Criteria: Patients aged 12-80 may be eligible\* to receive bone marrow for transplantation through the Ossium HOPE Program if: Their treating physician determined they are eligible for allogeneic bone marrow transplant Their treating physician determined that the potential benefit outweighs the potential risks

Interventions

OTHER

Bone Marrow Transplant with Ossium's HPC, Marrow (bone marrow recovered from deceased organ and tissue donors)

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Bone Marrow Transplant (BMT)

Locations

University of Alabama, Birmingham

Birmingham, Alabama 35294

United States

Henry Ford Health

Detroit, Michigan 48202

United States

The Ohio State University Medical Center

Columbus, Ohio 43210

United States

Tristar Centennial Medical Center

Nashville, Tennessee 37203

United States